Downward pressure on prices to reduce healthcare spending are a permanent fixture in the pharmaceutical sector today and into the future.
As PMPRB modernization and the shift towards affordability are finalized, manufacturers must be more agile than ever.
The 5th Annual Pharma Symposium will provide a setting for strategic discussion among industry stakeholders about their expectations moving forward:
- What will be the impact of the PMPRB Guidelines Review?
- How is the regulatory landscape shifting in pharma?
- How can patient maintain access to the drugs they need?
- What can Canada learn from international examples of access and reimbursement regimes?
Join our email list to stay tuned for updates! Stay tuned for more details about our 2019 program. Reserve your space today:
Click for more information.